Anti-COQ2 monoclonal antibody

Pre-made anti-COQ2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to COQ2/COQ2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0592-Ab-1/ GM-Tg-hg-IP0592-Ab-2Anti-Human COQ2 monoclonal antibodyHuman
GM-Tg-rg-IP0592-Ab-1/ GM-Tg-rg-IP0592-Ab-2Anti-Rat COQ2 monoclonal antibodyRat
GM-Tg-mg-IP0592-Ab-1/ GM-Tg-mg-IP0592-Ab-2Anti-Mouse COQ2 monoclonal antibodyMouse
GM-Tg-cynog-IP0592-Ab-1/ GM-Tg-cynog-IP0592-Ab-2Anti-Cynomolgus/ Rhesus macaque COQ2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0592-Ab-1/ GM-Tg-felg-IP0592-Ab-2Anti-Feline COQ2 monoclonal antibodyFeline
GM-Tg-cang-IP0592-Ab-1/ GM-Tg-cang-IP0592-Ab-2Anti-Canine COQ2 monoclonal antibodyCanine
GM-Tg-bovg-IP0592-Ab-1/ GM-Tg-bovg-IP0592-Ab-2Anti-Bovine COQ2 monoclonal antibodyBovine
GM-Tg-equg-IP0592-Ab-1/ GM-Tg-equg-IP0592-Ab-2Anti-Equine COQ2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0592-Ab-1/ GM-Tg-hg-IP0592-Ab-2; GM-Tg-rg-IP0592-Ab-1/ GM-Tg-rg-IP0592-Ab-2;
GM-Tg-mg-IP0592-Ab-1/ GM-Tg-mg-IP0592-Ab-2; GM-Tg-cynog-IP0592-Ab-1/ GM-Tg-cynog-IP0592-Ab-2;
GM-Tg-felg-IP0592-Ab-1/ GM-Tg-felg-IP0592-Ab-2; GM-Tg-cang-IP0592-Ab-1/ GM-Tg-cang-IP0592-Ab-2;
GM-Tg-bovg-IP0592-Ab-1/ GM-Tg-bovg-IP0592-Ab-2; GM-Tg-equg-IP0592-Ab-1/ GM-Tg-equg-IP0592-Ab-2
Products NameAnti-COQ2 monoclonal antibody
Formatmab
Target NameCOQ2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-COQ2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0592-Ag-1Recombinant multi-species COQ2/ CL640/ COQ10D1 protein


    Target information

    Target IDGM-IP0592
    Target NameCOQ2
    Gene ID27235,71883,498332,707681,478457,101084704,504633,100061199
    Gene Symbol and Synonyms2310002F18Rik,CL640,COQ10D1,COQ2,MSA1,PHB:PPT,RGD1306722
    Uniprot AccessionQ96H96,Q499N4,Q2KIQ4
    Uniprot Entry NameCOQ2_HUMAN,COQ2_RAT,COQ2_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000173085
    Target ClassificationN/A

    The target: COQ2, gene name: COQ2, also named as CL640, COQ10D1, MSA1, PHB:PPT. This gene encodes an enzyme that functions in the final steps in the biosynthesis of CoQ (ubiquinone), a redox carrier in the mitochondrial respiratory chain and a lipid-soluble antioxidant. This enzyme, which is part of the coenzyme Q10 pathway, catalyzes the prenylation of parahydroxybenzoate with an all-trans polyprenyl group. Mutations in this gene cause coenzyme Q10 deficiency, a mitochondrial encephalomyopathy, and also COQ2 nephropathy, an inherited form of mitochondriopathy with primary renal involvement. [provided by RefSeq, Oct 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.